United States

Corporate earnings, M&A, IPOs, and business developments from the United States.

ENSG INVESTIGATION: Investigation Launched into The Ensign Group, Inc. and Attorneys Encourage Investors and Potential Witnesses to Contact Robbins Geller Rudman & Dowd LLP

by

SAN DIEGO, July 6, 2026 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving The Ensign Group, Inc. (NASDAQ: ENSG). If you any have information that could assist in the Ensign investigation or if you are an Ensign… Source: prnewswire Country: United States

AI Energy Pivot Complete: LIXTE Biotechnology Finishes Corporate Rebrand to NOMAD Power Solutions, Begins Trading Under Nasdaq: NMAD

by

Issued on behalf of NOMAD Power Solutions, Inc. (Nasdaq: NMAD), formerly LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT) NOMAD Power Solutions, Inc. has completed its corporate name change from LIXTE Biotechnology Holdings, Inc. and begins trading today under the new Nasdaq ticker NMAD,… Source: prnewswire Country: United States

Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2026 Earnings Results Conference Call

by

MEXICO CITY, July 6, 2026 /PRNewswire/ — Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”) today announced that it will report its Second Quarter 2026 Earnings Results on Wednesday, July 22, 2026, after the Mexican Stock Exchange (BMV) close. The… Source: prnewswire Country: United States

GardaWorld Announces Closing of US$200 Million Additional Senior Notes due 2032 and US$300 Million Incremental Term Loans

by

MONTRÉAL, July 6, 2026 /PRNewswire/ – Garda World Security Corporation (“GardaWorld” or the “Company”), an entrepreneurial-driven corporation focused on building global champions in security services, AI-enabled security technology, integrated risk management and cash automation… Source: prnewswire Country: United States

A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs

by

Issued on behalf of GT Biopharma, Inc. GT Biopharma, Inc. (NASDAQ: GTBP) said it has integrated AI-based tools across the discovery and engineering of its tumor-targeting NK cell engagers and multi-domain proteins, efficiency gains the company expects to push multiple new development… Source: prnewswire Country: United States

DexKo Global Announces CEO Transition; Eric McGinnis Appointed Chief Executive Officer

by

NOVI, Mich., July 6, 2026 /PRNewswire/ — DexKo Global Inc. today announced that Chief Executive Officer Fred Bentley will transition to the role of Chairman of the Board, effective July 6, 2026. Eric McGinnis has been appointed Chief Executive Officer and will assume the role on the same… Source: prnewswire Country: United States